{"id":"W4212897494","doi":"10.3410/f.736683688.793565708","title":"Faculty Opinions recommendation of A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial.","year":2019,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto Western Hospital","funders":"Pfizer; Eli Lilly and Company; Amgen","keywords":"Ixekizumab; Adalimumab; Psoriatic arthritis; Medicine; Biosimilar; Psoriasis; Physical therapy; Dermatology; Internal medicine; Secukinumab; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001061062,0.0004827892,0.00264298,0.0002620852,0.0001267077,0.00003401612,0.0006910935,0.0004608989,0.00002856326],"category_scores_gemma":[0.008648598,0.0002526422,0.0002370354,0.001648754,0.0005137339,0.0001716078,0.0006511904,0.0006327854,0.000001408441],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009313042,"about_ca_system_score_gemma":0.0003841522,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001789652,"about_ca_topic_score_gemma":0.00007558232,"domain_scores_codex":[0.9945907,0.0007087781,0.002703651,0.0006733636,0.001046194,0.0002773025],"domain_scores_gemma":[0.991653,0.0006836976,0.0030803,0.001088323,0.003306587,0.0001880476],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.06395492,0.009253043,0.0003569874,0.005424673,0.0009290631,4.003277e-7,0.0008819363,2.974246e-7,0.000002472745,0.00003709583,0.8737465,0.04541259],"study_design_scores_gemma":[0.2464178,0.005289232,0.04980064,0.03390475,0.0004780059,0.000008633924,0.0001590017,0.000004200188,0.00002283993,0.000006673273,0.6636783,0.0002298773],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"dataset","genre_gemma":"dataset","genre_scores_codex":[0.004180061,0.002341027,0.000003081946,0.02341308,0.0003744742,0.009846251,0.9598178,0.000006131226,0.00001810979],"genre_scores_gemma":[0.00974192,0.001402775,0.0004958489,0.0003575335,0.00003936656,0.0003495457,0.9875548,0.00001882494,0.00003933284],"genre_candidate":"dataset","genre_consensus":"dataset","teacher_disagreement_score":0.2100681,"threshold_uncertainty_score":0.9999926,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08972734213381903,"score_gpt":0.4043947695602305,"score_spread":0.3146674274264114,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}